欧洲远端肾小管酸中毒注册研究:5年分析
该研究基于欧洲远端肾小管酸中毒(dRTA)注册库,前瞻性收集2019年2月至2024年5月214例患者数据。结果显示42%患者血碳酸氢根低于22 mmol/L,25%有高钙尿症;身高SDS与血碳酸氢根水平及早期诊断正相关。30岁以上患者eGFR显著降低,CKD≥2期患病率36%,SLC4A1变异者CKD风险更高。
要点
- dRTA患者代谢控制不佳普遍,42%血碳酸氢根低于22 mmol/L。
- 提高血碳酸氢根至24 mmol/L可能改善生长,尤其早期诊断者。
- SLC4A1变异患者CKD风险显著增加,需重点监测。
核心结论
- 在主要为儿童的dRTA队列中,代谢控制与生长改善相关,支持将血碳酸氢根治疗目标提高至24 mmol/L。
- dRTA患者从儿童期起CKD风险高于总体人群,尤其携带SLC4A1变异者。
研究设计与样本
- 欧洲dRTA注册库为欧洲罕见肾病网络(ERKNet)子注册库,前瞻性收集2019年2月至2024年5月数据。
- 共纳入214例患者,末次访视时仅22%年龄超过18岁,69%有遗传诊断。
- 采用logistic回归分析CKD和生长受损的预测因素。
主要发现
- 平均血碳酸氢根低于22 mmol/L者占42%,高钙尿症占25%,且不随年龄变化。
- 身高标准差评分(SDS)与血清碳酸氢根水平正相关(P = .008),与早期诊断正相关(P = .005)。
- 30岁以上患者eGFR显著更低(P < .001),总体CKD≥2期患病率为36%。
- SLC4A1变异患者CKD分期>1的风险更高(P = .013)。
关键数值与推荐
- 血碳酸氢根低于22 mmol/L定义为低碳酸氢根血症,见于42%患者。
- 高钙尿症见于25%患者。
- CKD≥2期患病率为36%。
- 身高SDS与血清碳酸氢根水平相关P = .008,与早期诊断相关P = .005。
- SLC4A1变异与CKD分期>1相关P = .013。
临床怎么用
- 对dRTA患者应积极控制代谢性酸中毒,考虑将血碳酸氢根目标设为24 mmol/L以改善生长。
- 早期诊断并监测肾功能,尤其对SLC4A1变异患者从儿童期开始关注CKD风险。
局限性
- 队列以儿童为主,成人数据有限。
- 为注册库观察性分析,可能存在选择偏倚和信息偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Distal renal tubular acidosis (dRTA) is characterized by metabolic acidosis, growth failure, nephrocalcinosis, nephrolithiasis and chronic kidney disease (CKD). Previous retrospective data suggested improved outcome with adequate metabolic control, but confirmation from prospective data is lacking. Since 2019, the European dRTA registry has collected prospective data on patients with dRTA. Herein we present results of the first data analysis. METHODS: The registry is hosted as a subregistry of the European Rare Kidney Disease Network (https://www.erknet.org/). In addition to the standard items of growth and plasma creatinine, additional data on plasma and urine biochemistries, genetics, treatment and clinical manifestations were collected from February 2019 through May 2024. Logistic regression analysis was used to identify predictors of CKD and impaired growth. RESULTS: Of the 214 patients enrolled in the registry, only 22% were aged >18 years at the last visit. A genetic diagnosis was documented in 69% of patients. On average, low blood bicarbonate levels (<22 mmol/L) and hypercalciuria were observed in 42% and 25% of patients, respectively, independently of age. Multivariable analysis showed that height standard deviation score (SDS) was positively associated with serum bicarbonate levels (P = .008) and with early diagnosis (P = .005). Further modelling based on odds ratios indicated substantial odds of impaired growth for low serum bicarbonate levels. Patients aged >30 years had significantly lower estimated glomerular filtration rate (P < .001) and the overall prevalence of CKD stage ≥2 was 36%. Patients with SLC4A1 variants were at higher risk of CKD stage >1 (P = .013). CONCLUSION: Our results in this primarily paediatric cohort highlight the importance of metabolic control and support increasing the blood bicarbonate level for therapy to 24 mmol/L to improve growth. Compared with the overall population, patients with dRTA are at higher risk of CKD from childhood, particularly if they have underlying SLC4A1 variants.
引用
- Giaccari M, Veligratli F, Hayes W, et al. The European distal renal tubular acidosis registry: a 5-year analysis. Nephrol Dial Transplant. 2026. PMID: 41790493. doi:10.1093/ndt/gfag051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。